FDA Issues Warning to CVS, Walgreens, and Others for Selling Unapproved Eye Products

The U.S. Food and Drug Administration (FDA) has issued warnings to eight companies, including CVS Health Corp and Walgreens Boots Alliance, for manufacturing or marketing unapproved eye products. These products are illegally marketed to treat conditions such as conjunctivitis, cataract, and glaucoma, posing an increased risk to users. Some of the products contain silver, which can cause permanent discoloration of the skin and eye tissues. CVS has already halted the sale of its "Pink Eye Relief Eye Drops" and is offering full refunds to customers. The FDA has given the companies 15 days to respond and correct the violations, warning that failure to do so may result in legal action.